Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Pierides

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Kidney International|July 1, 1980
Hemodialysis encephalopathy with osteomalacic fractures and muscle weaknessA M Pierides, W G Edwards, U X Cullum, et al.
The Quarterly Journal of Medicine|April 1, 1977
Idiopathic membranous nephropathyA M Pierides, P Malasit, A R Morley, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
The need and use of a phosphate-enriched dialysate during regular hemodialysisA M Pierides, H A Ellis, M K Ward, et al.
Mayo Clinic Proceedings|June 1, 1982
Reversible nonoliguric acute renal failure associated with zomepirac therapyJ T McCarthy, G L Schwartz, T J Blair, et al.
Lancet (London, England)|May 22, 1976
Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophyA M Pierides, H A Ellis, W Simpson, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1975
Assessment of renal osteodystrophy following renal transplantationA M Pierides, H A Ellis, K M Peart, et al.
Journal of Medical Genetics|December 1, 1976
Study on a family with anderson--Fabry's disease and associated familial spastic paraplegiaA M Pierides, G Holti, A L Crombie, et al.
Clinical Nephrology|April 1, 1976
1 alpha-hydroxycholecalciferol in hemodialysis renal osteodystrophy. Adverse effects of anticonvulsant therapyA M Pierides, D N Kerr, H A Ellis, et al.
Clinical Nephrology|September 1, 1978
Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patientsP Aljama, M K Ward, A M Pierides, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
Long term therapy with 1,25(OH)2D3 in dialysis bone diseaseA M Pierides, M K Ward, F Alvarez-Ude, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Kidney International|July 1, 1980
Hemodialysis encephalopathy with osteomalacic fractures and muscle weaknessA M Pierides, W G Edwards, U X Cullum, et al.
The Quarterly Journal of Medicine|April 1, 1977
Idiopathic membranous nephropathyA M Pierides, P Malasit, A R Morley, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
The need and use of a phosphate-enriched dialysate during regular hemodialysisA M Pierides, H A Ellis, M K Ward, et al.
Mayo Clinic Proceedings|June 1, 1982
Reversible nonoliguric acute renal failure associated with zomepirac therapyJ T McCarthy, G L Schwartz, T J Blair, et al.
Lancet (London, England)|May 22, 1976
Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophyA M Pierides, H A Ellis, W Simpson, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1975
Assessment of renal osteodystrophy following renal transplantationA M Pierides, H A Ellis, K M Peart, et al.
Journal of Medical Genetics|December 1, 1976
Study on a family with anderson--Fabry's disease and associated familial spastic paraplegiaA M Pierides, G Holti, A L Crombie, et al.
Clinical Nephrology|April 1, 1976
1 alpha-hydroxycholecalciferol in hemodialysis renal osteodystrophy. Adverse effects of anticonvulsant therapyA M Pierides, D N Kerr, H A Ellis, et al.
Clinical Nephrology|September 1, 1978
Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patientsP Aljama, M K Ward, A M Pierides, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
Long term therapy with 1,25(OH)2D3 in dialysis bone diseaseA M Pierides, M K Ward, F Alvarez-Ude, et al.
Pageof 6